Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors.

Saved in:
Bibliographic Details
Title: Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors.
Authors: Moik F; Medical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria.; Medical University of Vienna, Department of Medicine I, Division of Hematology and Hemostaseology; Comprehensive Cancer Center Vienna, Vienna, Austria., Riedl JM; Medical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Barth D; Medical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria., Berton F; Medical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria., Fink M; Medical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria., Englisch C; Medical University of Vienna, Department of Medicine I, Division of Hematology and Hemostaseology; Comprehensive Cancer Center Vienna, Vienna, Austria., Hoeller C; Medical University of Vienna, Department of Dermatology, Vienna, Austria., Fuereder T; Medical University of Vienna, Department of Medicine I, Division of Oncology, Vienna, Austria., Ay L; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute for Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna Healthcare Group, Vienna, Austria., Pabinger I; Medical University of Vienna, Department of Medicine I, Division of Hematology and Hemostaseology; Comprehensive Cancer Center Vienna, Vienna, Austria., Richtig E; Department of Dermatology, Medical University of Graz, Graz, Austria., John N; Division of Pulmonology; Department of Internal Medicine, Medical University of Graz, Graz, Austria., Kostmann SM; Medical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria., Jost PJ; Medical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria., Gerger A; Medical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria., Terbuch A; Medical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria., Preusser M; Medical University of Vienna, Department of Medicine I, Division of Oncology, Vienna, Austria.; Medical University of Vienna, Christian Doppler Laboratory for Personalized Immunotherapy, Vienna, Austria., Ay C; Medical University of Vienna, Department of Medicine I, Division of Hematology and Hemostaseology; Comprehensive Cancer Center Vienna, Vienna, Austria.
Source: JACC. CardioOncology [JACC CardioOncol] 2024 Nov 12; Vol. 6 (6), pp. 965-975. Date of Electronic Publication: 2024 Nov 12 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101761697 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-0873 (Electronic) Linking ISSN: 26660873 NLM ISO Abbreviation: JACC CardioOncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-0873
DOI:10.1016/j.jaccao.2024.09.007